首页 > 最新文献

Acta Biomaterialia最新文献

英文 中文
A sulfonated cartilage interpenetrating polymer network reinforces and protects the extracellular matrix of degraded cartilage 磺化的软骨互穿聚合物网络加强和保护降解软骨的细胞外基质。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2025-12-15 DOI: 10.1016/j.actbio.2025.12.028
Christian D. DeMoya , Pierson Husted , Dev R. Mehrotra , Michael B. Albro , Brian D. Snyder , Mark W. Grinstaff
Cartilage extracellular matrix (ECM) comprises a type-II collagen fibril network that affords structure and tensile strength, complemented by a negatively charged, sulfated glycosaminoglycan (GAG) matrix that retains interstitial water. These components act synergistically, bestowing the rheological and tribological material properties essential to cartilage function. At the onset of osteoarthritis, a disease characterized by cartilage degeneration, GAGs diminish from the ECM reducing interstitial fluid load support (IFLS), equilibrium stiffness, and transferring load to the collagen fibril network, which subsequently breaks down, culminating in increased hydraulic permeability, and decreased cartilage stiffness. We restore the material properties of damaged cartilage critical to diarthrodial joint function by forming an interpenetrating polymer network (IPN) with the native collagen using a synthetic, hydrophilic, and biocompatible GAG-mimetic polymer. Upon visible light activation, the monomer, 3-sulfopropylmethacrylate (SPM), and the crosslinker, polyethylene glycol diacrylate (PEGDA), form a sulfonated and anionic IPN that fills the existing porous collagen matrix of degraded cartilage. Mechanistically, the highly sulfonated, anionic SPM IPN retards water transport, reestablishes collagen fibril network integrity, and restores tissue equilibrium stiffness, thereby returning the stiffness and viscoelastic properties of degraded cartilage to levels near healthy cartilage. Additionally, the SPM IPN protects cartilage by reducing the infiltration of inflammatory cytokines that are known to upregulate catabolic matrix metalloproteinases and downregulate GAG production.

Statement of significance

Amelioration of OA requires a comprehensive approach: neutralize or impede catabolic enzymes that degrade cartilage and reconstitute damaged cartilage by augmenting tissue ECM constituents. Currently, there are no clinical treatments that restore the viscoelastic material properties of hyaline cartilage tissue critical to its mechanical function and impart chondroprotection after OA induction. This work suggests that reconstituting GAG-depleted cartilage using a synthetic sulfonated interpenetrating polymer to reestablish IFLS instilled into the joint and polymerized with white light during conventional arthroscopy represents an effective, and minimally invasive strategy to restore the material properties of cartilage in the early stages of OA.
软骨细胞外基质(ECM)包括提供结构和抗拉强度的ii型胶原纤维网络,辅以带负电荷的硫酸化糖胺聚糖(GAG)基质,保留间质水分。这些成分协同作用,赋予软骨功能所必需的流变学和摩擦学材料特性。骨关节炎是一种以软骨退行性变为特征的疾病,在发病时,ECM中的GAGs减少,减少了间质液负载支持(IFLS)、平衡刚度和将负载传递给胶原原纤维网络,胶原原纤维网络随后分解,最终导致水力渗透性增加和软骨刚度降低。我们使用一种人工合成的、亲水的、生物相容性的模拟gag聚合物,通过与天然胶原形成互穿聚合物网络(IPN),恢复受损软骨的材料特性,这对diarthrodial关节功能至关重要。在可见光活化下,单体3-磺基丙基甲基丙烯酸酯(SPM)和交联剂聚乙二醇二丙烯酸酯(PEGDA)形成磺化和阴离子IPN,填充降解软骨现有的多孔胶原基质。在机械上,高度磺化的阴离子SPM IPN阻滞了水运输,重建胶原原纤维网络的完整性,恢复组织平衡刚度,从而使退化软骨的刚度和粘弹性恢复到接近健康软骨的水平。此外,SPM IPN保护软骨减少炎性细胞因子的浸润,炎性细胞因子可上调分解代谢基质金属蛋白酶并下调GAG的产生。意义声明:OA的改善需要综合的方法:通过增加组织ECM成分来中和或阻碍降解软骨的分解代谢酶并重建受损软骨。目前,临床还没有一种治疗方法可以恢复透明软骨组织的粘弹性材料特性,这对其机械功能至关重要,并赋予OA诱导后的软骨保护作用。这项研究表明,在常规关节镜检查期间,使用合成磺化互穿聚合物重建gag缺失的软骨,以重建注入关节并在白光下聚合的IFLS,是一种有效的微创策略,可以恢复OA早期软骨的材料特性。
{"title":"A sulfonated cartilage interpenetrating polymer network reinforces and protects the extracellular matrix of degraded cartilage","authors":"Christian D. DeMoya ,&nbsp;Pierson Husted ,&nbsp;Dev R. Mehrotra ,&nbsp;Michael B. Albro ,&nbsp;Brian D. Snyder ,&nbsp;Mark W. Grinstaff","doi":"10.1016/j.actbio.2025.12.028","DOIUrl":"10.1016/j.actbio.2025.12.028","url":null,"abstract":"<div><div>Cartilage extracellular matrix (ECM) comprises a type-II collagen fibril network that affords structure and tensile strength, complemented by a negatively charged, sulfated glycosaminoglycan (GAG) matrix that retains interstitial water. These components act synergistically, bestowing the rheological and tribological material properties essential to cartilage function. At the onset of osteoarthritis, a disease characterized by cartilage degeneration, GAGs diminish from the ECM reducing interstitial fluid load support (IFLS), equilibrium stiffness, and transferring load to the collagen fibril network, which subsequently breaks down, culminating in increased hydraulic permeability, and decreased cartilage stiffness. We restore the material properties of damaged cartilage critical to diarthrodial joint function by forming an interpenetrating polymer network (IPN) with the native collagen using a synthetic, hydrophilic, and biocompatible GAG-mimetic polymer. Upon visible light activation, the monomer, 3-sulfopropylmethacrylate (SPM), and the crosslinker, polyethylene glycol diacrylate (PEGDA), form a sulfonated and anionic IPN that fills the existing porous collagen matrix of degraded cartilage. Mechanistically, the highly sulfonated, anionic SPM IPN retards water transport, reestablishes collagen fibril network integrity, and restores tissue equilibrium stiffness, thereby returning the stiffness and viscoelastic properties of degraded cartilage to levels near healthy cartilage. Additionally, the SPM IPN protects cartilage by reducing the infiltration of inflammatory cytokines that are known to upregulate catabolic matrix metalloproteinases and downregulate GAG production.</div></div><div><h3>Statement of significance</h3><div>Amelioration of OA requires a comprehensive approach: neutralize or impede catabolic enzymes that degrade cartilage and reconstitute damaged cartilage by augmenting tissue ECM constituents. Currently, there are no clinical treatments that restore the viscoelastic material properties of hyaline cartilage tissue critical to its mechanical function and impart chondroprotection after OA induction. This work suggests that reconstituting GAG-depleted cartilage using a synthetic sulfonated interpenetrating polymer to reestablish IFLS instilled into the joint and polymerized with white light during conventional arthroscopy represents an effective, and minimally invasive strategy to restore the material properties of cartilage in the early stages of OA.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 202-215"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145776415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dual Inhibition of KRAS G12D and PI3K/BRD4 signaling overcomes therapeutic resistance in pancreatic cancer KRAS G12D和PI3K/BRD4信号的双重抑制克服了胰腺癌的治疗耐药
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2025-12-26 DOI: 10.1016/j.actbio.2025.12.049
Yashwardhan Ghanwatkar, Sohan Mahto, Ajaykumar Chittipolu, Raghu Ramanathan, Prakash Shrestha, Ram I. Mahato
Oncogenic KRAS G12D mutations drive pancreatic ductal adenocarcinoma (PDAC) but face therapeutic resistance from pathway reactivation. We synthesized MDP5, a dual BRD4/PI3K inhibitor, to address this issue. When combined with the KRAS G12D inhibitor MRTX1133, MDP5 resensitized resistant cancer cells. This combination synergistically enhanced apoptosis and proliferation inhibition, outperforming the standard-of-care, Gemcitabine (GEM). This dual-inhibition strategy effectively counters resistance mechanisms in KRAS-mutant PDAC, offering a promising therapeutic approach. We formulated MUC4-targeted polymeric nanoparticles co-loading MRTX1133 (8.3%) and MDP5 (7.4%) that exhibited pH-responsive release and uniform morphology. This targeted delivery translated to superior anti-tumor efficacy, as the combination of NPs markedly reduced tumor burden more effectively than single-drug treatments or a polymer-Gemcitabine conjugate. Importantly, this potent therapeutic effect was achieved without inducing detectable liver highlighting the potential, safe, and effective cancer therapy. Mechanistically, dual targeting reduced p-AKT and YAP1, depleted CD44+/ALDH+ cancer-stem-like cells, and reprogrammed the tumor immune microenvironment by elevating CD8a and CD86 while lowering Ly-6 G. Targeted co-delivery of MRTX1133 and MDP5 simultaneously inhibits the KRAS G12D and PI3K pathways. This dual-action approach aims to overcome therapeutic resistance, offering potentially more durable and precise treatment for patients with KRAS G12D-mutant pancreatic cancer.

Statement of significance

Pancreatic ductal adenocarcinoma (PDAC) is commonly driven by KRAS G12D, yet the KRAS G12D inhibitor MRTX1133 faces rapid adaptive resistance and delivery hurdles. We engineered MUC4-targeted polymer nanoparticles that co-deliver MRTX1133 with MDP5, a dual BRD4/PI3K blocker. The particles show uniform size, high loading, and pH-triggered release, increasing intratumoral drug levels versus free drugs. In orthotopic PDAC, the combination outperformed monotherapies and gemcitabine without overt toxicity. Mechanistically, dual inhibition suppresses AKT/YAP signaling, depletes CD44+/ALDH+ cells, and shifts the tumor immune milieu (↑CD8a, ↑CD86, ↓Ly-6 G). By integrating molecular targeting with multi-pathway blockade, this work addresses two major barriers—resistance and delivery—and outlines a generalizable strategy to improve precision nano therapy for KRAS-mutant pancreatic cancer.
致癌KRAS G12D突变驱动胰腺导管腺癌(PDAC),但面临通路再激活的治疗抗性。我们合成了MDP5,一种双BRD4/PI3K抑制剂,来解决这个问题。当与KRAS G12D抑制剂MRTX1133联合使用时,MDP5可使耐药癌细胞重致敏。这种组合协同增强了细胞凋亡和增殖抑制,优于标准治疗的吉西他滨(GEM)。这种双抑制策略有效地对抗kras突变PDAC的耐药机制,提供了有前途的治疗方法。我们制备了靶向muc4的聚合物纳米颗粒,共负载MRTX1133(8.3%)和MDP5(7.4%),具有ph响应释放和均匀形态。这种靶向递送转化为卓越的抗肿瘤疗效,因为NPs联合使用比单药治疗或聚合物-吉西他滨结合物更有效地减少了肿瘤负荷。重要的是,这种有效的治疗效果是在没有诱导可检测到的肝脏的情况下实现的,这突出了潜在的、安全的和有效的癌症治疗。机制上,双靶向降低了p-AKT和YAP1,减少了CD44+/ALDH+癌症干细胞,并通过升高CD8a和CD86而降低y- 6g来重新编程肿瘤免疫微环境。靶向共递送MRTX1133和MDP5同时抑制KRAS G12D和PI3K途径。这种双作用方法旨在克服治疗耐药性,为KRAS g12d突变胰腺癌患者提供更持久和精确的治疗。意义声明:胰腺导管腺癌(PDAC)通常由KRAS G12D驱动,但KRAS G12D抑制剂MRTX1133面临快速适应性耐药和递送障碍。我们设计了靶向muc4的聚合物纳米颗粒,可与MDP5(一种BRD4/PI3K双阻断剂)共同递送MRTX1133。颗粒大小均匀,高负荷,ph触发释放,与游离药物相比,肿瘤内药物水平增加。在原位PDAC中,联合治疗优于单药治疗和吉西他滨,且无明显毒性。机制上,双重抑制抑制AKT/YAP信号,消耗CD44+/ALDH+细胞,并改变肿瘤免疫环境(↑CD8a,↑CD86,↓y- 6g)。通过将分子靶向与多通路阻断相结合,本研究解决了两大主要障碍——耐药和递送——并概述了一种可推广的策略,以提高kras突变型胰腺癌的精确纳米治疗。
{"title":"Dual Inhibition of KRAS G12D and PI3K/BRD4 signaling overcomes therapeutic resistance in pancreatic cancer","authors":"Yashwardhan Ghanwatkar,&nbsp;Sohan Mahto,&nbsp;Ajaykumar Chittipolu,&nbsp;Raghu Ramanathan,&nbsp;Prakash Shrestha,&nbsp;Ram I. Mahato","doi":"10.1016/j.actbio.2025.12.049","DOIUrl":"10.1016/j.actbio.2025.12.049","url":null,"abstract":"<div><div>Oncogenic KRAS G12D mutations drive pancreatic ductal adenocarcinoma (PDAC) but face therapeutic resistance from pathway reactivation. We synthesized MDP5, a dual BRD4/PI3K inhibitor, to address this issue. When combined with the KRAS G12D inhibitor MRTX1133, MDP5 resensitized resistant cancer cells. This combination synergistically enhanced apoptosis and proliferation inhibition, outperforming the standard-of-care, Gemcitabine (GEM). This dual-inhibition strategy effectively counters resistance mechanisms in KRAS-mutant PDAC, offering a promising therapeutic approach. We formulated MUC4-targeted polymeric nanoparticles co-loading MRTX1133 (8.3%) and MDP5 (7.4%) that exhibited pH-responsive release and uniform morphology. This targeted delivery translated to superior anti-tumor efficacy, as the combination of NPs markedly reduced tumor burden more effectively than single-drug treatments or a polymer-Gemcitabine conjugate. Importantly, this potent therapeutic effect was achieved without inducing detectable liver highlighting the potential, safe, and effective cancer therapy. Mechanistically, dual targeting reduced p-AKT and YAP1, depleted CD44<sup>+</sup>/ALDH<sup>+</sup> cancer-stem-like cells, and reprogrammed the tumor immune microenvironment by elevating CD8a and CD86 while lowering Ly-6 G. Targeted co-delivery of MRTX1133 and MDP5 simultaneously inhibits the KRAS G12D and PI3K pathways. This dual-action approach aims to overcome therapeutic resistance, offering potentially more durable and precise treatment for patients with KRAS G12D-mutant pancreatic cancer.</div></div><div><h3>Statement of significance</h3><div>Pancreatic ductal adenocarcinoma (PDAC) is commonly driven by KRAS G12D, yet the KRAS G12D inhibitor MRTX1133 faces rapid adaptive resistance and delivery hurdles. We engineered MUC4-targeted polymer nanoparticles that co-deliver MRTX1133 with MDP5, a dual BRD4/PI3K blocker. The particles show uniform size, high loading, and pH-triggered release, increasing intratumoral drug levels versus free drugs. In orthotopic PDAC, the combination outperformed monotherapies and gemcitabine without overt toxicity. Mechanistically, dual inhibition suppresses AKT/YAP signaling, depletes CD44<sup>+</sup>/ALDH<sup>+</sup> cells, and shifts the tumor immune milieu (↑CD8a, ↑CD86, ↓Ly-6 G). By integrating molecular targeting with multi-pathway blockade, this work addresses two major barriers—resistance and delivery—and outlines a generalizable strategy to improve precision nano therapy for KRAS-mutant pancreatic cancer.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 637-654"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145851663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tunable wrinkled topographies direct dendritic cell maturation and immune phenotypes 可调节的皱褶地形直接树突状细胞成熟和免疫表型。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2025-12-30 DOI: 10.1016/j.actbio.2025.12.050
Ajay Chavda , Xingwu Zhou , Mohammad Asadi Tokmedash , James J. Moon , Jouha Min
Dendritic cells (DCs) are potent regulators of immunity with therapeutic potential in cancer, autoimmune disorders, and implant tolerance. However, clinical translation is limited by poor scalability, limited survival/retention after delivery, and difficulty controlling DC immune responses. Biomaterials have been explored to address these challenges, but the role of surface topography in DC regulation remains poorly understood. Here, we used a custom bottom-up nanofabrication method to create wrinkled multilayer coatings with precisely tunable nano-, submicro-, and microscale topographies. Using this platform, we systematically investigated the impact of topographical cues on DC behavior, using the DC2.4 cell line and primary bone marrow-derived DCs (BMDCs) as biological models. We found that distinct topographies drive DCs toward divergent phenotypes. Microscale wrinkles promoted an immunogenic mature state, with elevated pro-inflammatory cytokines (IL-6, IL-12, and TNF-α), high co-stimulation and NF-κB activation, and strong T-cell activation potential. Submicro-scale patterns induced an intermediate mature state with homeostatic and tolerogenic potential. Submicro exhibited increased TGF-β and IL-10, reduced cross-presentation, and weak T-cell activation in the DC2.4 cell line. However, BMDCs expressed intermediate maturation marker levels and NF-κB activation without increased cytokine secretion. In contrast, nanoscale wrinkles and planar controls preserved DC immaturity with high antigen uptake and low maturation, though planar surfaces showed poor adhesion, limiting their utility for delivery or ex vivo culture. These findings identify surface topography as a key regulator of DC immune programming. Our versatile, scalable fabrication strategy provides a broadly applicable platform for probing immune cell–material interactions and advancing biomaterials for DC-based immunotherapies and related applications.

Statement of significance

Immune therapies increasingly rely on dendritic cells (DCs), yet current biomaterials mainly use biochemical signals to guide their behavior. This study introduces a new approach using precisely engineered surface topographies to influence DC function through physical cues alone. By creating tunable wrinkled MXene coatings, we show for the first time that different topographical scales can maintain DC immaturity or induce maturation with either homeostatic or immunogenic polarization potential. Unlike prior studies that focus on general surface roughness or chemistry, we demonstrate a topography-specific effect validated in both cell line and primary DCs. This work establishes surface architecture as a powerful design parameter for immune-instructive biomaterials, with potential to improve vaccine development and cell-based immunotherapies.
树突状细胞(dc)是一种有效的免疫调节细胞,具有治疗癌症、自身免疫性疾病和植入物耐受的潜力。然而,临床翻译受到可扩展性差、分娩后生存/保留有限以及难以控制DC免疫反应的限制。生物材料已经被探索来解决这些挑战,但是表面形貌在直流调节中的作用仍然知之甚少。在这里,我们使用自定义的自下而上纳米制造方法来创建具有精确可调纳米,亚微米和微尺度拓扑结构的褶皱多层涂层。利用这个平台,我们系统地研究了地形线索对DC行为的影响,使用DC2.4细胞系和原代骨髓源性DC (bmdc)作为生物学模型。我们发现,不同的地形驱动DCs向不同的表型。微尺度皱纹促进免疫原性成熟状态,促炎因子(IL-6、IL-12和TNF-α)升高,高共刺激和NF-κB活化,t细胞活化电位强。亚微尺度模式诱导了具有稳态和耐受性潜力的中间成熟状态。亚微细胞在DC2.4细胞系中表现为TGF-β和IL-10增加,交叉呈现减少,t细胞激活弱。然而,BMDCs表达中等成熟标志物水平和NF-κB活化,而细胞因子分泌不增加。相比之下,纳米尺度皱褶和平面对照保留了DC的不成熟性,具有高抗原摄取和低成熟度,尽管平面表面表现出较差的粘附性,限制了它们在递送或离体培养中的应用。这些发现表明,表面形貌是DC免疫规划的关键调节因子。我们的多功能,可扩展的制造策略提供了一个广泛适用的平台,用于探测免疫细胞-材料相互作用和推进基于dc的免疫疗法和相关应用的生物材料。意义声明:免疫治疗越来越依赖树突状细胞(dc),但目前的生物材料主要使用生化信号来指导其行为。本研究介绍了一种新的方法,使用精确设计的表面地形,仅通过物理线索来影响直流功能。通过创建可调谐的皱褶MXene涂层,我们首次表明不同的地形尺度可以维持DC不成熟或诱导成熟,无论是稳态还是免疫原性极化电位。与之前的研究不同,这些研究关注的是一般的表面粗糙度或化学性质,我们在细胞系和原代dc中都证明了地形特异性效应。这项工作确立了表面结构作为免疫指导性生物材料的强大设计参数,具有改善疫苗开发和基于细胞的免疫疗法的潜力。
{"title":"Tunable wrinkled topographies direct dendritic cell maturation and immune phenotypes","authors":"Ajay Chavda ,&nbsp;Xingwu Zhou ,&nbsp;Mohammad Asadi Tokmedash ,&nbsp;James J. Moon ,&nbsp;Jouha Min","doi":"10.1016/j.actbio.2025.12.050","DOIUrl":"10.1016/j.actbio.2025.12.050","url":null,"abstract":"<div><div>Dendritic cells (DCs) are potent regulators of immunity with therapeutic potential in cancer, autoimmune disorders, and implant tolerance. However, clinical translation is limited by poor scalability, limited survival/retention after delivery, and difficulty controlling DC immune responses. Biomaterials have been explored to address these challenges, but the role of surface topography in DC regulation remains poorly understood. Here, we used a custom bottom-up nanofabrication method to create wrinkled multilayer coatings with precisely tunable nano-, submicro-, and microscale topographies. Using this platform, we systematically investigated the impact of topographical cues on DC behavior, using the DC2.4 cell line and primary bone marrow-derived DCs (BMDCs) as biological models. We found that distinct topographies drive DCs toward divergent phenotypes. Microscale wrinkles promoted an immunogenic mature state, with elevated pro-inflammatory cytokines (IL-6, IL-12, and TNF-α), high co-stimulation and NF-κB activation, and strong T-cell activation potential. Submicro-scale patterns induced an intermediate mature state with homeostatic and tolerogenic potential. Submicro exhibited increased TGF-β and IL-10, reduced cross-presentation, and weak T-cell activation in the DC2.4 cell line. However, BMDCs expressed intermediate maturation marker levels and NF-κB activation without increased cytokine secretion. In contrast, nanoscale wrinkles and planar controls preserved DC immaturity with high antigen uptake and low maturation, though planar surfaces showed poor adhesion, limiting their utility for delivery or <em>ex vivo</em> culture. These findings identify surface topography as a key regulator of DC immune programming. Our versatile, scalable fabrication strategy provides a broadly applicable platform for probing immune cell–material interactions and advancing biomaterials for DC-based immunotherapies and related applications.</div></div><div><h3>Statement of significance</h3><div>Immune therapies increasingly rely on dendritic cells (DCs), yet current biomaterials mainly use biochemical signals to guide their behavior. This study introduces a new approach using precisely engineered surface topographies to influence DC function through physical cues alone. By creating tunable wrinkled MXene coatings, we show for the first time that different topographical scales can maintain DC immaturity or induce maturation with either homeostatic or immunogenic polarization potential. Unlike prior studies that focus on general surface roughness or chemistry, we demonstrate a topography-specific effect validated in both cell line and primary DCs. This work establishes surface architecture as a powerful design parameter for immune-instructive biomaterials, with potential to improve vaccine development and cell-based immunotherapies.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 428-443"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145890163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanical characterization of infarcted porcine hearts using left anterior descending and left circumflex coronary artery models 用左前降和左旋冠状动脉模型研究猪心肌梗死的力学特性。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2026-01-05 DOI: 10.1016/j.actbio.2025.12.051
Nicolás Laita , Alejandro Aparici-Gil , Aida Oliván-Viguera , Alba Pérez-Martínez , Ming Wu , Manuel García de Yébenes , Gloria Abizanda , Stephan Janssens , Felipe Prósper , Manuel M. Mazo Vega , Miguel Ángel Martínez , Manuel Doblaré , Estefanía Peña
This study comprehensively analyzes passive mechanical and structural changes of cardiac tissue 6 weeks after myocardial infarction (MI) by biaxial, simple triaxial shear, and confined compression characterization. We considered a porcine model, comparing two MI types: Left Anterior Descending (LAD) artery and Left Circumflex (LCX) artery occlusions. LAD model generated apical transmurally infarcted hearts, while the LCX model generated medial heterogeneous infarctions ranging from mild locally infarcted tissue to transmurally infarcted tissue. Infarcted tissue exhibited significantly higher stiffness than healthy tissue. When peak equibiaxial stretch increases up to 20%, the stress increase is 2.19 for medial locally infarcted tissue, 4.49 for medial fully infarcted tissue, and 6.26 for apical fully infarcted tissue. Fully infarcted animals showed significant macroscopic geometrical remodeling, with thickness reductions in the infarcted area of 45%–60%, while locally infarcted tissue showed no thinning. The anisotropy of healthy myocardium was also altered post-MI: medial infarcts exhibited preferentially circumferential anisotropy, while apical infarctions increased isotropy. Histological analysis validated these mechanical alterations, revealing a substantial increase in collagen content in infarcted regions. In LCX infarctions, collagen distribution was uniformly aligned, whereas in LAD ones, its distribution was spatially heterogeneous. Non-infarcted tissue far from the infarction did not exhibit changes in mechanical properties or collagen content, suggesting a localized effect at least 6 weeks post-MI. These findings highlight the importance of considering the extent and location of MI when developing personalized therapeutic strategies.
Statement of Significance
This work provides a comprehensive mechanical and histological assessment of post-infarct porcine myocardium using advanced multimodal testing. Unlike previous studies, we compare two infarct types (LAD and LCX) under identical conditions and examine regional and severity-dependent differences in stiffness, compressibility, and anisotropy. We show that infarction induces local rather than global changes in tissue passive mechanics, modulated by infarct geometry and scar distribution. These insights support more accurate cardiac modeling and may guide personalized therapeutic strategies after myocardial infarction.
本研究综合分析心肌梗死(MI)后6周心肌组织的被动力学和结构变化,采用双轴、简单三轴剪切和受限压缩表征。我们考虑了猪模型,比较了两种心肌梗死类型:左前降支(LAD)动脉和左旋动脉(LCX)闭塞。LAD模型生成顶端跨壁梗死心脏,LCX模型生成内侧非均匀梗死,范围从轻度局部梗死组织到跨壁梗死组织。梗死组织的硬度明显高于健康组织。当峰值等双轴拉伸增加到20%时,内侧局部梗死组织的应力增加为2.19,内侧完全梗死组织的应力增加为4.49,顶端完全梗死组织的应力增加为6.26。完全梗死的动物表现出明显的重塑,梗死区域的厚度减少了45%-60%,而局部梗死组织没有变薄。心肌梗死后健康心肌的各向异性也发生了改变:内侧梗死优先表现为周向各向异性,而顶端梗死增加了各向异性。组织学分析证实了这些机械改变,显示梗死区域胶原蛋白含量显著增加。在LCX梗死中,胶原分布均匀排列,而在LAD梗死中,胶原分布具有空间异质性。远离梗死的非梗死组织在机械性能或胶原蛋白含量方面没有表现出变化,表明心肌梗死后至少6周有局部作用。这些发现强调了在制定个性化治疗策略时考虑心肌梗死的范围和位置的重要性。这项工作提供了一个全面的机械和组织学评估梗死后猪心肌使用先进的多模态试验。与之前的研究不同,我们在相同的条件下比较了两种梗死类型(LAD和LCX),并检查了区域和严重程度相关的刚度、可压缩性和各向异性差异。我们表明,梗死诱导局部而不是组织被动力学的全局变化,由梗死几何形状和疤痕分布调节。这些见解支持更准确的心脏建模,并可能指导心肌梗死后的个性化治疗策略。
{"title":"Mechanical characterization of infarcted porcine hearts using left anterior descending and left circumflex coronary artery models","authors":"Nicolás Laita ,&nbsp;Alejandro Aparici-Gil ,&nbsp;Aida Oliván-Viguera ,&nbsp;Alba Pérez-Martínez ,&nbsp;Ming Wu ,&nbsp;Manuel García de Yébenes ,&nbsp;Gloria Abizanda ,&nbsp;Stephan Janssens ,&nbsp;Felipe Prósper ,&nbsp;Manuel M. Mazo Vega ,&nbsp;Miguel Ángel Martínez ,&nbsp;Manuel Doblaré ,&nbsp;Estefanía Peña","doi":"10.1016/j.actbio.2025.12.051","DOIUrl":"10.1016/j.actbio.2025.12.051","url":null,"abstract":"<div><div>This study comprehensively analyzes passive mechanical and structural changes of cardiac tissue 6 weeks after myocardial infarction (MI) by biaxial, simple triaxial shear, and confined compression characterization. We considered a porcine model, comparing two MI types: Left Anterior Descending (LAD) artery and Left Circumflex (LCX) artery occlusions. LAD model generated apical transmurally infarcted hearts, while the LCX model generated medial heterogeneous infarctions ranging from mild locally infarcted tissue to transmurally infarcted tissue. Infarcted tissue exhibited significantly higher stiffness than healthy tissue. When peak equibiaxial stretch increases up to 20%, the stress increase is 2.19 for medial locally infarcted tissue, 4.49 for medial fully infarcted tissue, and 6.26 for apical fully infarcted tissue. Fully infarcted animals showed significant macroscopic geometrical remodeling, with thickness reductions in the infarcted area of 45%–60%, while locally infarcted tissue showed no thinning. The anisotropy of healthy myocardium was also altered post-MI: medial infarcts exhibited preferentially circumferential anisotropy, while apical infarctions increased isotropy. Histological analysis validated these mechanical alterations, revealing a substantial increase in collagen content in infarcted regions. In LCX infarctions, collagen distribution was uniformly aligned, whereas in LAD ones, its distribution was spatially heterogeneous. Non-infarcted tissue far from the infarction did not exhibit changes in mechanical properties or collagen content, suggesting a localized effect at least 6 weeks post-MI. These findings highlight the importance of considering the extent and location of MI when developing personalized therapeutic strategies.</div><div><em>Statement of Significance</em></div><div>This work provides a comprehensive mechanical and histological assessment of post-infarct porcine myocardium using advanced multimodal testing. Unlike previous studies, we compare two infarct types (LAD and LCX) under identical conditions and examine regional and severity-dependent differences in stiffness, compressibility, and anisotropy. We show that infarction induces local rather than global changes in tissue passive mechanics, modulated by infarct geometry and scar distribution. These insights support more accurate cardiac modeling and may guide personalized therapeutic strategies after myocardial infarction.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 459-480"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145919375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Matrix-modulating pH-gated hydrogel for coordinated regulation of cancer-associated fibroblast phenotype and Mn²⁺-STING activation for enhanced tumor immunotherapy 基质调节ph门控水凝胶协调调节癌症相关成纤维细胞表型和Mn 2 + -STING激活增强肿瘤免疫治疗。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2026-01-08 DOI: 10.1016/j.actbio.2026.01.014
Tinghua Li, Yazhen Wang, Jiahui Zhu, Xiaoxian Zhang, Xuequan Zhang, Lei Lei, Lianyi Yang, Peng Wang, Qiusheng Wang, Ziyun He, Bin He, Jun Cao
The tumor microenvironment (TME), particularly its cancer-associated fibroblast (CAF)-driven fibrotic stroma and immunosuppressive components, forms intertwined physical and immune barriers that impede the efficacy of immunotherapy. To address this challenge, we developed a pH-gated hydrogel platform to modulate CAF-resulted TME barriers and activate potent antitumor immunity. This dynamic network, constructed by Schiff base crosslinking between carboxymethyl chitosan and aldehyde-functionalized hyaluronic acid, was utilized for the co-delivery of pirfenidone (PFD) and manganese-curcumin nanoparticles (MC). In the acidic TME, PFD was released rapidly from hydrogel to modulate CAF phenotype, thereby attenuating the formation of fibrotic stroma. The internalized MC orchestrated three synergistic therapeutic functions: (1) suppressing VEGF-mediated angiogenesis via curcumin, (2) generating reactive oxygen species through Mn²⁺-catalyzed Fenton-like reactions, and (3) promoting dendritic cell maturation by activating the cGAS-STING pathway with Mn²⁺. Upon 808 nm NIR laser irradiation, MC exhibited potent photothermal conversion efficacy, inducing localized hyperthermia that further amplified ROS production, and triggered immunogenic cell death. This coordinated cascade thereby elicited robust antitumor immunity, as evidenced by the upregulated expression of proinflammatory cytokines (TNF-α, IFN-γ, IL-6) and enhanced CD8⁺ T cell infiltration. Notably, this strategy achieved marked tumor regression in B16F10 melanoma-bearing mice. Thus, this work established a TME-responsive platform that coordinated barrier modulation with multimodal therapeutic synergy, providing a promising paradigm for solid tumor immunotherapy.

Statement of significance

Modulating the tumor microenvironment (TME) by targeting cancer-associated fibroblasts (CAFs) represent a promising strategy to enhance the efficacy of immunotherapy. Here, we develop a pH-gated hydrogel platform that enables the controlled delivery of pirfenidone and manganese-curcumin nanoparticles (MC), thereby facilitating the regulation of CAF-mediated fibrotic barriers followed by the activation of antitumor immunity. The released MC integrate antiangiogenic activity, ROS amplification, STING pathway activation, and photothermal ablation into a unified therapeutic system. Moreover, the photothermal effect further amplifies ROS generation and STING signaling, resulting in remodeling of the TME. This coordinated cascade elicits robust T-cell activation and cytokine secretion, achieving marked tumor eradication in murine melanoma models. Overall, this study establishes a therapeutic paradigm that integrates stromal barrier modulation with immune activation to achieve more effective tumor treatment.
肿瘤微环境(TME),特别是其与癌症相关的成纤维细胞(CAF)驱动的纤维化基质和免疫抑制成分,形成了相互交织的物理和免疫屏障,阻碍了免疫治疗的疗效。为了应对这一挑战,我们开发了一种ph门控水凝胶平台来调节ca导致的TME屏障并激活有效的抗肿瘤免疫。该动态网络由羧甲基壳聚糖和醛功能化透明质酸之间的希夫碱交联构建,用于吡非尼酮(PFD)和锰姜黄素纳米颗粒(MC)的共递送。在酸性TME中,PFD从水凝胶中迅速释放,调节CAF表型,从而减弱纤维化基质的形成。内化的MC协调了三个协同治疗功能:(1)通过姜黄素抑制vegf介导的血管生成,(2)通过Mn 2⁺催化fenton样反应产生活性氧,(3)通过Mn 2⁺激活cGAS-STING途径促进树突状细胞成熟。在808 nm近红外激光照射下,MC表现出强大的光热转化功效,诱导局部热疗,进一步放大ROS的产生,并引发免疫原性细胞死亡。这种协调的级联因此引发了强大的抗肿瘤免疫,证实了促炎细胞因子(TNF-α、IFN-γ、IL-6)表达上调和CD8 + T细胞浸润增强。值得注意的是,该策略在B16F10黑色素瘤小鼠中实现了明显的肿瘤消退。因此,这项工作建立了一个tme响应平台,协调屏障调节和多模式治疗协同作用,为实体肿瘤免疫治疗提供了一个有希望的范例。意义声明:通过靶向癌症相关成纤维细胞(CAFs)来调节肿瘤微环境(TME)是提高免疫治疗疗效的一种有前景的策略。在这里,我们开发了一个ph门控的水凝胶平台,可以控制吡非尼酮和锰姜黄素纳米颗粒(MC)的递送,从而促进了caff介导的纤维化屏障的调节,随后激活抗肿瘤免疫。释放的MC将抗血管生成活性、ROS扩增、STING通路激活和光热消融整合到一个统一的治疗系统中。此外,光热效应进一步放大ROS的产生和STING信号,导致TME的不可逆重塑。这种协调的级联引起强大的t细胞激活和细胞因子分泌,在小鼠黑色素瘤模型中实现几乎完全的肿瘤根除。总的来说,本研究建立了一种结合基质屏障调节和免疫激活的治疗模式,以实现更有效的肿瘤治疗。
{"title":"Matrix-modulating pH-gated hydrogel for coordinated regulation of cancer-associated fibroblast phenotype and Mn²⁺-STING activation for enhanced tumor immunotherapy","authors":"Tinghua Li,&nbsp;Yazhen Wang,&nbsp;Jiahui Zhu,&nbsp;Xiaoxian Zhang,&nbsp;Xuequan Zhang,&nbsp;Lei Lei,&nbsp;Lianyi Yang,&nbsp;Peng Wang,&nbsp;Qiusheng Wang,&nbsp;Ziyun He,&nbsp;Bin He,&nbsp;Jun Cao","doi":"10.1016/j.actbio.2026.01.014","DOIUrl":"10.1016/j.actbio.2026.01.014","url":null,"abstract":"<div><div>The tumor microenvironment (TME), particularly its cancer-associated fibroblast (CAF)-driven fibrotic stroma and immunosuppressive components, forms intertwined physical and immune barriers that impede the efficacy of immunotherapy. To address this challenge, we developed a pH-gated hydrogel platform to modulate CAF-resulted TME barriers and activate potent antitumor immunity. This dynamic network, constructed by Schiff base crosslinking between carboxymethyl chitosan and aldehyde-functionalized hyaluronic acid, was utilized for the co-delivery of pirfenidone (PFD) and manganese-curcumin nanoparticles (MC). In the acidic TME, PFD was released rapidly from hydrogel to modulate CAF phenotype, thereby attenuating the formation of fibrotic stroma. The internalized MC orchestrated three synergistic therapeutic functions: (1) suppressing VEGF-mediated angiogenesis <em>via</em> curcumin, (2) generating reactive oxygen species through Mn²⁺-catalyzed Fenton-like reactions, and (3) promoting dendritic cell maturation by activating the cGAS-STING pathway with Mn²⁺. Upon 808 nm NIR laser irradiation, MC exhibited potent photothermal conversion efficacy, inducing localized hyperthermia that further amplified ROS production, and triggered immunogenic cell death. This coordinated cascade thereby elicited robust antitumor immunity, as evidenced by the upregulated expression of proinflammatory cytokines (TNF-α, IFN-γ, IL-6) and enhanced CD8⁺ T cell infiltration. Notably, this strategy achieved marked tumor regression in B16F10 melanoma-bearing mice. Thus, this work established a TME-responsive platform that coordinated barrier modulation with multimodal therapeutic synergy, providing a promising paradigm for solid tumor immunotherapy.</div></div><div><h3>Statement of significance</h3><div>Modulating the tumor microenvironment (TME) by targeting cancer-associated fibroblasts (CAFs) represent a promising strategy to enhance the efficacy of immunotherapy. Here, we develop a pH-gated hydrogel platform that enables the controlled delivery of pirfenidone and manganese-curcumin nanoparticles (MC), thereby facilitating the regulation of CAF-mediated fibrotic barriers followed by the activation of antitumor immunity. The released MC integrate antiangiogenic activity, ROS amplification, STING pathway activation, and photothermal ablation into a unified therapeutic system. Moreover, the photothermal effect further amplifies ROS generation and STING signaling, resulting in remodeling of the TME. This coordinated cascade elicits robust T-cell activation and cytokine secretion, achieving marked tumor eradication in murine melanoma models. Overall, this study establishes a therapeutic paradigm that integrates stromal barrier modulation with immune activation to achieve more effective tumor treatment.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 655-670"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145949435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current progress of bio-fabrication in breast reconstruction 生物制造在乳房再造术中的研究进展。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2026-01-08 DOI: 10.1016/j.actbio.2026.01.015
Xuanwei Zhang, Zhuohang Du, Zhenxing Wang, Chao Luo, Jiaming Sun
Breast reconstruction is essential for restoring self-image and quality of life after mastectomy. While current methods using implants or autologous tissue are prevalent, they face challenges such as capsular contracture and volume loss. This review explores how bio-fabrication strategies are generating innovative scaffolds to overcome these limitations. We discuss the clinical use of bio-fabrication and detail preclinical progress in key areas: enhancing the biocompatibility and safety of implants, achieving soft tissue regeneration and vascularization, integrating antitumor therapy with reconstruction, and optimizing aesthetic outcomes. Finally, we outline future research directions for developing superior biomaterials to advance breast reconstruction.

Statement of significance

Current breast reconstruction methods are limited by complications, such as capsular contracture, volume loss, and infection. This review underscores the promise of bioengineered scaffolds, where biomaterials combined with bioactive agents and advanced fabrication (e.g., 3D printing) can recreate the natural breast microenvironment to support regeneration. This replication is crucial for promoting vascularization, adipogenesis, and tissue integration. Furthermore, we explore new strategies for modifying implant surfaces to minimize fibrosis and infection risks. This work serves as a guide for developing next-generation regenerative scaffolds and highlights their potential to significantly improve clinical outcomes in breast reconstruction by providing personalized, biocompatible, and functionally' as none of the work so far in the literature can truly replicate the natural breast microenvironment.
乳房重建是乳房切除术后恢复自我形象和生活质量的必要条件。虽然目前使用植入物或自体组织的方法很普遍,但它们面临着诸如包膜挛缩和体积损失等挑战。这篇综述探讨了生物制造策略如何产生创新的支架来克服这些限制。我们讨论了生物制造的临床应用,并详细介绍了关键领域的临床前进展:增强植入物的生物相容性和安全性,实现软组织再生和血管化,将抗肿瘤治疗与重建相结合,以及优化美学结果。最后,我们展望了未来的研究方向,以开发更好的生物材料来推进乳房重建。意义声明:目前的乳房重建方法受到并发症的限制,如包膜挛缩、体积损失和感染。这篇综述强调了生物工程支架的前景,其中生物材料与生物活性剂和先进制造(例如3D打印)相结合可以重建自然乳房微环境以支持再生。这种复制对于促进血管形成、脂肪生成和组织整合至关重要。此外,我们探索了修改植入物表面的新策略,以尽量减少纤维化和感染风险。这项工作为下一代再生支架的开发提供了指导,并强调了它们在乳房重建中显著改善临床结果的潜力,因为迄今为止文献中没有任何一项工作能够真正复制自然乳房微环境。
{"title":"Current progress of bio-fabrication in breast reconstruction","authors":"Xuanwei Zhang,&nbsp;Zhuohang Du,&nbsp;Zhenxing Wang,&nbsp;Chao Luo,&nbsp;Jiaming Sun","doi":"10.1016/j.actbio.2026.01.015","DOIUrl":"10.1016/j.actbio.2026.01.015","url":null,"abstract":"<div><div>Breast reconstruction is essential for restoring self-image and quality of life after mastectomy. While current methods using implants or autologous tissue are prevalent, they face challenges such as capsular contracture and volume loss. This review explores how bio-fabrication strategies are generating innovative scaffolds to overcome these limitations. We discuss the clinical use of bio-fabrication and detail preclinical progress in key areas: enhancing the biocompatibility and safety of implants, achieving soft tissue regeneration and vascularization, integrating antitumor therapy with reconstruction, and optimizing aesthetic outcomes. Finally, we outline future research directions for developing superior biomaterials to advance breast reconstruction.</div></div><div><h3>Statement of significance</h3><div>Current breast reconstruction methods are limited by complications, such as capsular contracture, volume loss, and infection. This review underscores the promise of bioengineered scaffolds, where biomaterials combined with bioactive agents and advanced fabrication (e.g., 3D printing) can recreate the natural breast microenvironment to support regeneration. This replication is crucial for promoting vascularization, adipogenesis, and tissue integration. Furthermore, we explore new strategies for modifying implant surfaces to minimize fibrosis and infection risks. This work serves as a guide for developing next-generation regenerative scaffolds and highlights their potential to significantly improve clinical outcomes in breast reconstruction by providing personalized, biocompatible, and functionally' as none of the work so far in the literature can truly replicate the natural breast microenvironment.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 145-167"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145949382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-assembled charge-complementary hydrogel with sustained release of antimicrobial peptides for periodontitis treatment 具有抗菌肽缓释的自组装电荷互补水凝胶治疗牙周炎。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2026-01-14 DOI: 10.1016/j.actbio.2026.01.025
Wener Chen , Chaoning Zhan , Chengfei Zhang , Conrado Aparicio , Simin Peng , Zhou Ye , Yifan Lin
Periodontitis is a pathogenic microbial-infected disease where immune dysregulation promotes chronic inflammation and excessive osteoclast activity, causing progressive tissue destruction. Current therapeutic approaches face challenges in achieving sustained drug release in periodontal pockets. In this study, we construct a self-assembled peptide hydrogel by combining negatively charged peptide amphiphile (PA) with positively charged antimicrobial peptide GL13K, namely PA/GL13K. GL13K electrostatically binds to self-assembled PA nanofibers, promoting PA self-assembly that yields a denser hydrogel network. This structural reinforcement enables sustained GL13K release. The PA/GL13K hydrogel demonstrates potent antibacterial effects and immunomodulatory properties, suppressing pro-inflammatory M1 macrophage polarization while promoting anti-inflammatory M2 macrophage activation. Moreover, the PA/GL13K hydrogel inhibits osteoclast differentiation in vitro. In an experimental periodontitis mouse model, local periodontal injection of the PA/GL13K hydrogel reduced inflammatory infiltration and osteoclast-mediated bone resorption, effectively mitigating periodontal tissue destruction. These findings suggest that the self-assembled peptide hydrogel system may represent a potential multifunctional therapeutic approach for periodontal treatment.

Statement of significance

This study presents a peptide-based hydrogel system designed for the comprehensive treatment of periodontitis, addressing critical challenges in current therapeutic strategies. The self-assembled charge-complementary hydrogel is composed of negatively charged peptide amphiphile (PA) and positively charged antimicrobial peptide GL13K. GL13K electrostatically binds to self-assembled PA nanofibers, promoting PA self-assembly that yields a denser hydrogel network. This structural reinforcement enables sustained GL13K release. The system demonstrates synergistic effects, including antibacterial activity, immunomodulatory effects, and inhibition of osteoclastogenesis. Our findings highlight the hydrogel’s potential as a promising platform for periodontitis management, combining structural optimization with multifunctional therapeutic outcomes.
牙周炎是一种致病性微生物感染疾病,其中免疫失调促进慢性炎症和过度破骨细胞活性,导致进行性组织破坏。目前的治疗方法面临着在牙周袋中实现持续药物释放的挑战。在本研究中,我们将带负电荷的肽两亲体(PA)与带正电荷的抗菌肽GL13K结合,构建了一种自组装肽水凝胶,即PA/GL13K。GL13K静电结合到自组装的PA纳米纤维上,促进PA自组装,产生更密集的水凝胶网络。这种结构加固使GL13K持续释放。PA/GL13K水凝胶显示出强大的抗菌作用和免疫调节特性,抑制促炎M1巨噬细胞极化,促进抗炎M2巨噬细胞活化。此外,PA/GL13K水凝胶在体外抑制破骨细胞分化。在实验性牙周炎小鼠模型中,局部牙周注射PA/GL13K水凝胶可减少炎症浸润和破骨细胞介导的骨吸收,有效减轻牙周组织破坏。这些发现表明,自组装肽水凝胶系统可能代表一种潜在的多功能牙周治疗方法。意义声明:本研究提出了一种基于肽的水凝胶系统,用于牙周炎的综合治疗,解决了当前治疗策略中的关键挑战。自组装的电荷互补水凝胶由带负电荷的肽类两亲体(PA)和带正电荷的抗菌肽GL13K组成。GL13K静电结合到自组装的PA纳米纤维上,促进PA自组装,产生更密集的水凝胶网络。这种结构加固使GL13K持续释放。该系统显示出协同作用,包括抗菌活性、免疫调节作用和抑制破骨细胞生成。我们的研究结果强调了水凝胶作为牙周炎治疗的一个有前途的平台的潜力,将结构优化与多功能治疗结果相结合。
{"title":"Self-assembled charge-complementary hydrogel with sustained release of antimicrobial peptides for periodontitis treatment","authors":"Wener Chen ,&nbsp;Chaoning Zhan ,&nbsp;Chengfei Zhang ,&nbsp;Conrado Aparicio ,&nbsp;Simin Peng ,&nbsp;Zhou Ye ,&nbsp;Yifan Lin","doi":"10.1016/j.actbio.2026.01.025","DOIUrl":"10.1016/j.actbio.2026.01.025","url":null,"abstract":"<div><div>Periodontitis is a pathogenic microbial-infected disease where immune dysregulation promotes chronic inflammation and excessive osteoclast activity, causing progressive tissue destruction. Current therapeutic approaches face challenges in achieving sustained drug release in periodontal pockets. In this study, we construct a self-assembled peptide hydrogel by combining negatively charged peptide amphiphile (PA) with positively charged antimicrobial peptide GL13K, namely PA/GL13K. GL13K electrostatically binds to self-assembled PA nanofibers, promoting PA self-assembly that yields a denser hydrogel network. This structural reinforcement enables sustained GL13K release. The PA/GL13K hydrogel demonstrates potent antibacterial effects and immunomodulatory properties, suppressing pro-inflammatory M1 macrophage polarization while promoting anti-inflammatory M2 macrophage activation. Moreover, the PA/GL13K hydrogel inhibits osteoclast differentiation <em>in vitro</em>. In an experimental periodontitis mouse model, local periodontal injection of the PA/GL13K hydrogel reduced inflammatory infiltration and osteoclast-mediated bone resorption, effectively mitigating periodontal tissue destruction. These findings suggest that the self-assembled peptide hydrogel system may represent a potential multifunctional therapeutic approach for periodontal treatment.</div></div><div><h3>Statement of significance</h3><div>This study presents a peptide-based hydrogel system designed for the comprehensive treatment of periodontitis, addressing critical challenges in current therapeutic strategies. The self-assembled charge-complementary hydrogel is composed of negatively charged peptide amphiphile (PA) and positively charged antimicrobial peptide GL13K. GL13K electrostatically binds to self-assembled PA nanofibers, promoting PA self-assembly that yields a denser hydrogel network. This structural reinforcement enables sustained GL13K release. The system demonstrates synergistic effects, including antibacterial activity, immunomodulatory effects, and inhibition of osteoclastogenesis. Our findings highlight the hydrogel’s potential as a promising platform for periodontitis management, combining structural optimization with multifunctional therapeutic outcomes.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 251-265"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145992286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
M2 macrophage-derived exosome nanoplatform for targeted H2S delivery to alleviate hepatic ischemia–reperfusion injury via synergistic anti-oxidative, anti-inflammatory, and anti-ferroptotic effects M2巨噬细胞来源的外泌体纳米平台通过协同抗氧化、抗炎和抗铁效应靶向递送H2S减轻肝缺血再灌注损伤。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2025-12-18 DOI: 10.1016/j.actbio.2025.12.041
Tianci Zuo , Chengge Shi , Jiayu Li , Diwei Li , Xiaoming Luo , Mengzhu Xu , Mingli Su , Hongyang Lu , Yanmei Zhang , Xiaowen Hu , Qiang Zhou , Quazi T.H. Shubhra , Xiaosong He , Xiaojun Cai
Hepatic ischemia-reperfusion injury (HIRI) presents a critical challenge in liver surgery, transplantation, and trauma, driven by the interplay of oxidative stress, inflammation, and ferroptosis. Current treatments are limited by poor targeting and insufficient efficacy. Here, we develop a liver-targeted exosomal nanoplatform (DATS@M2-Exos) by encapsulating the H2S donor diallyl trisulfide (DATS) into M2 macrophage-derived exosomes (M2-Exos), enabling liver-specific H2S delivery. In vitro, DATS@M2-Exos exhibit good biocompatibility, efficient cellular uptake, and effective H2S release, resulting in significant suppression of oxidative stress, inflammation, and ferroptosis by restoring GSH levels, enhancing GPX4 expression, and reducing Fe2+ and MDA accumulation. In a murine HIRI model, DATS@M2-Exos demonstrate strong hepatic tropism, significantly decrease serum ALT/AST levels, alleviate histopathological injury, while exhibiting favorable safety. RNA sequencing reveals potent antioxidant and anti-ferroptosis effects of DATS@M2-Exos via redox and lipid metabolic reprogramming, including activation of the GSH metabolic pathway, suppression of iron overload, and enhancement of GPX4 expression. Furthermore, DATS@M2-Exos exert dual immunomodulatory effects by suppressing the TNF-α/IL-1β/MAPK13 axis and promoting M2 macrophage polarization through activation of the PPAR pathway. This study presents an exosome-based nanotherapeutic for the targeted delivery of H2S to coordinately combat oxidative stress, inflammation, and ferroptosis, offering a precise and effective strategy for HIRI treatment.

Statement of significance

Hepatic ischemia-reperfusion injury (HIRI) remains a critical challenge in liver surgery and transplantation, driven by oxidative stress, inflammation, and ferroptosis. Current therapies lack targeted delivery and multimodal efficacy. This study develops a liver-targeted exosomal nanoplatform (DATS@M2-Exos) by encapsulating the H₂S donor diallyl trisulfide (DATS) into M2 macrophage-derived exosomes (M2-Exos). DATS@M2-Exos demonstrate exceptional hepatic tropism, biocompatibility, and controlled H2S release, synergistically combating oxidative stress (via GSH/GPX4 axis activation), inflammation (via PPAR-mediated M2 polarization), and ferroptosis (via iron overload suppression). In vivo, DATS@M2-Exos significantly reduce liver damage with no systemic toxicity. This work pioneers an exosome-based gas therapy platform, offering a precise, multifunctional strategy for HIRI and broader oxidative stress-related diseases.
肝缺血再灌注损伤(HIRI)是肝脏手术、移植和创伤中的一个关键挑战,是氧化应激、炎症和铁下垂相互作用的结果。目前的治疗受到靶向性差和疗效不足的限制。在这里,我们开发了一个肝脏靶向外泌体纳米平台(DATS@M2-Exos),通过将H2S供体二烯丙基三硫化物(DATS)封装到M2巨噬细胞来源的外泌体(M2- exos)中,实现肝脏特异性H2S递送。在体外,DATS@M2-Exos表现出良好的生物相容性、高效的细胞摄取和有效的H2S释放,通过恢复GSH水平、增强GPX4表达、减少Fe2+和MDA积累,显著抑制氧化应激、炎症和铁下沉。在小鼠HIRI模型中,DATS@M2-Exos表现出强烈的肝向性,显著降低血清ALT/AST水平,减轻组织病理学损伤,同时具有良好的安全性。RNA测序显示DATS@M2-Exos通过氧化还原和脂质代谢重编程具有强大的抗氧化和抗铁凋亡作用,包括激活GSH代谢途径,抑制铁过载,增强GPX4表达。DATS@M2-Exos通过激活PPAR通路,抑制TNF-α/IL-1β/MAPK13轴,促进M2巨噬细胞极化,发挥双重免疫调节作用。本研究提出了一种基于外泌体的纳米疗法,用于靶向递送H2S,以协调对抗氧化应激、炎症和铁下沉,为HIRI治疗提供了一种精确有效的策略。肝缺血再灌注损伤(HIRI)仍然是肝脏手术和移植的一个关键挑战,由氧化应激、炎症和铁下垂驱动。目前的治疗方法缺乏靶向递送和多模式疗效。本研究通过将h2s供体二烯丙基三硫醚(DATS)包封到M2巨噬细胞来源的外泌体(M2- exos)中,开发了肝脏靶向外泌体纳米平台(DATS@M2-Exos)。DATS@M2-Exos表现出特殊的肝向性、生物相容性和可控的H2S释放,协同对抗氧化应激(通过GSH/GPX4轴激活)、炎症(通过ppar介导的M2极化)和铁中毒(通过铁过载抑制)。在体内,DATS@M2-Exos显著减少肝损伤,无全身毒性。这项工作开创了一个基于外泌体的气体治疗平台,为HIRI和更广泛的氧化应激相关疾病提供了精确的多功能策略。
{"title":"M2 macrophage-derived exosome nanoplatform for targeted H2S delivery to alleviate hepatic ischemia–reperfusion injury via synergistic anti-oxidative, anti-inflammatory, and anti-ferroptotic effects","authors":"Tianci Zuo ,&nbsp;Chengge Shi ,&nbsp;Jiayu Li ,&nbsp;Diwei Li ,&nbsp;Xiaoming Luo ,&nbsp;Mengzhu Xu ,&nbsp;Mingli Su ,&nbsp;Hongyang Lu ,&nbsp;Yanmei Zhang ,&nbsp;Xiaowen Hu ,&nbsp;Qiang Zhou ,&nbsp;Quazi T.H. Shubhra ,&nbsp;Xiaosong He ,&nbsp;Xiaojun Cai","doi":"10.1016/j.actbio.2025.12.041","DOIUrl":"10.1016/j.actbio.2025.12.041","url":null,"abstract":"<div><div>Hepatic ischemia-reperfusion injury (HIRI) presents a critical challenge in liver surgery, transplantation, and trauma, driven by the interplay of oxidative stress, inflammation, and ferroptosis. Current treatments are limited by poor targeting and insufficient efficacy. Here, we develop a liver-targeted exosomal nanoplatform (DATS@M2-Exos) by encapsulating the H<sub>2</sub>S donor diallyl trisulfide (DATS) into M2 macrophage-derived exosomes (M2-Exos), enabling liver-specific H<sub>2</sub>S delivery. <em>In vitro</em>, DATS@M2-Exos exhibit good biocompatibility, efficient cellular uptake, and effective H<sub>2</sub>S release, resulting in significant suppression of oxidative stress, inflammation, and ferroptosis by restoring GSH levels, enhancing GPX4 expression, and reducing Fe<sup>2+</sup> and MDA accumulation. In a murine HIRI model, DATS@M2-Exos demonstrate strong hepatic tropism, significantly decrease serum ALT/AST levels, alleviate histopathological injury, while exhibiting favorable safety. RNA sequencing reveals potent antioxidant and anti-ferroptosis effects of DATS@M2-Exos via redox and lipid metabolic reprogramming, including activation of the GSH metabolic pathway, suppression of iron overload, and enhancement of GPX4 expression. Furthermore, DATS@M2-Exos exert dual immunomodulatory effects by suppressing the TNF-α/IL-1β/MAPK13 axis and promoting M2 macrophage polarization through activation of the PPAR pathway. This study presents an exosome-based nanotherapeutic for the targeted delivery of H<sub>2</sub>S to coordinately combat oxidative stress, inflammation, and ferroptosis, offering a precise and effective strategy for HIRI treatment.</div></div><div><h3>Statement of significance</h3><div>Hepatic ischemia-reperfusion injury (HIRI) remains a critical challenge in liver surgery and transplantation, driven by oxidative stress, inflammation, and ferroptosis. Current therapies lack targeted delivery and multimodal efficacy. This study develops a liver-targeted exosomal nanoplatform (DATS@M2-Exos) by encapsulating the H₂S donor diallyl trisulfide (DATS) into M2 macrophage-derived exosomes (M2-Exos). DATS@M2-Exos demonstrate exceptional hepatic tropism, biocompatibility, and controlled H<sub>2</sub>S release, synergistically combating oxidative stress (via GSH/GPX4 axis activation), inflammation (via PPAR-mediated M2 polarization), and ferroptosis (via iron overload suppression). <em>In vivo</em>, DATS@M2-Exos significantly reduce liver damage with no systemic toxicity. This work pioneers an exosome-based gas therapy platform, offering a precise, multifunctional strategy for HIRI and broader oxidative stress-related diseases.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 593-612"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145800967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “A dissolvable microneedle platform for the delivery of tumor-derived total RNA nanovaccines for enhanced tumor immunotherapy” [Acta Biomaterialia 2025, 199, 120-131] “用于肿瘤衍生的总RNA纳米疫苗的可溶解微针平台,用于增强肿瘤免疫治疗”[生物材料学报,2025,1999,120 -131]。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2026-01-06 DOI: 10.1016/j.actbio.2025.12.036
Jiachen Wang , Sicong Huang , Huiye Wei , Simin Liang , Yuan Ding , Zecong Xiao , Xintao Shuai
{"title":"Corrigendum to “A dissolvable microneedle platform for the delivery of tumor-derived total RNA nanovaccines for enhanced tumor immunotherapy” [Acta Biomaterialia 2025, 199, 120-131]","authors":"Jiachen Wang ,&nbsp;Sicong Huang ,&nbsp;Huiye Wei ,&nbsp;Simin Liang ,&nbsp;Yuan Ding ,&nbsp;Zecong Xiao ,&nbsp;Xintao Shuai","doi":"10.1016/j.actbio.2025.12.036","DOIUrl":"10.1016/j.actbio.2025.12.036","url":null,"abstract":"","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 866-867"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145919335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Morphogenesis of the diamond-type stereom microlattice and the origin of saddle-shaped minimal surfaces in the echinoderm skeleton 棘皮动物骨架中菱形立体微晶格的形态发生及鞍形最小表面的起源。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-03-01 Epub Date: 2026-01-08 DOI: 10.1016/j.actbio.2026.01.016
Kamil Humański , Giulio Facchini , Jenifer Croce , Dorota Kołbuk , Philippe Dubois , Przemysław Gorzelak
<div><div>Echinoderm endoskeleton has a unique trabecular microstructure, called stereom, which can exhibit highly ordered geometries. A striking example of these geometries is the recently discovered “diamond-type” stereom, characterized by a diamond triply periodic minimal surface (D-TPMS) and distinguished by exceptional mechanical and structural properties. Despite its promise for engineering applications, the morphogenesis of this microarchitecture remains poorly understood. Here, we applied a multimodal imaging and labeling approach to investigate the developmental processes underlying the formation of the diamond-type stereom in adults of a starfish <em>Protoreaster nodosus</em>. We showed that this stereom type develops through two principal marginal growth patterns: trabecular trifurcation, which typically occurs horizontally on flat external plate surfaces, oriented approximately along the crystallographic {111} planes of the <span>d</span>-TPMS; and trabecular bifurcation, which generally occurs along plate edges and between trifurcating zones, aligned with the crystallographic {100} planes of the <span>d</span>-TPMS. Although these growth patterns may proceed at different rates, they are tightly coordinated, producing the coherent D-TPMS microarchitecture. Furthermore, we demonstrated that F-actin cytoskeletal deposition is consistently associated with active biomineralization fronts in both diamond-type and less ordered, galleried stereom. Notably, the formation of lateral bridges between adjacent stereom trabeculae is often preceded by catenoid-like F-actin structures, suggesting a guiding and templating role for the cytoskeleton in building trabecular connectivity and shaping its curvature. Given the recurrence of saddle-like features across stereom types, we hypothesize that minimal-surface geometries may emerge from tension-driven cytoskeletal dynamics acting as physical templates during biomineralization. Our observations underscore the critical involvement of the cytoskeleton in adult echinoderm biomineralization.</div></div><div><h3>Statement of significance</h3><div>Triple periodic minimal surfaces (TPMS) are geometrically regular, three-dimensionally repeating surfaces that minimize area by maintaining zero mean curvature. Among them, the diamond-type (D-TPMS) is notable for exceptional mechanical stability, uniform porosity, and low surface area-to-volume ratio. Although TPMS-like microarchitectures occur in nature, D-TPMS structures, with large lattice parameters (>10 µm) are exceedingly rare; one natural example is the stereom of certain echinoderms. Yet the mechanism governing the formation of such ordered microstructures remains unresolved. We applied a multi-modal approach to investigate principles of diamond-type stereom morphogenesis. Our results provide key insight into the growth dynamics of this microarchitecture and highlight the essential role of the cytoskeleton, particularly F-actin, in guiding trabecular c
棘皮动物的内骨骼具有独特的小梁结构,称为立体结构,可以呈现高度有序的几何形状。这些几何形状的一个显著例子是最近发现的“金刚石型”立体,其特征是金刚石三周期最小表面(D-TPMS),并具有卓越的机械和结构性能。尽管它在工程应用上有希望,但这种微结构的形态发生仍然知之甚少。在这里,我们应用了多模态成像和标记方法来研究成年海星Protoreaster nodosus钻石型立体形成的发育过程。我们发现这种立体类型通过两种主要的边缘生长模式发展:小梁三分岔,通常在平坦的外板表面水平发生,大约沿着D-TPMS的晶体学{111}面取向;小梁分叉,通常发生在板块边缘和三分带之间,与D-TPMS的晶体学{100}面对齐。虽然这些生长模式可能以不同的速度进行,但它们是紧密协调的,产生连贯的D-TPMS微结构。此外,我们证明了f -肌动蛋白细胞骨架沉积始终与活跃的生物矿化前沿相关,无论是在钻石型还是不太有序的,画廊体中。值得注意的是,相邻的立体小梁之间的横向桥的形成通常先于链状的f -肌动蛋白结构,这表明细胞骨架在构建小梁连通性和塑造其曲率方面具有指导和模板作用。鉴于鞍状特征在立体类型中反复出现,我们假设在生物矿化过程中,最小表面几何形状可能来自张力驱动的细胞骨架动力学,作为物理模板。我们的观察强调了细胞骨架在成年棘皮动物生物矿化中的关键作用。意义说明:三周期最小曲面(TPMS)是几何规则的三维重复曲面,通过保持零平均曲率来最小化面积。其中,金刚石型(D-TPMS)具有优异的机械稳定性、均匀的孔隙率和较低的表面积体积比。虽然类似tpms的微结构在自然界中存在,但具有大晶格参数(bbb10µm)的D-TPMS结构非常罕见;一个自然的例子是某些棘皮动物的身体。然而,控制这种有序微观结构形成的机制仍未得到解决。我们应用多模态方法研究了金刚石型立体形态发生的原理。我们的研究结果为这种微结构的生长动力学提供了关键的见解,并强调了细胞骨架,特别是f -肌动蛋白,在指导小梁连接和最小表面几何形状的出现方面的重要作用,无论是周期性的还是不规则的立体类型。
{"title":"Morphogenesis of the diamond-type stereom microlattice and the origin of saddle-shaped minimal surfaces in the echinoderm skeleton","authors":"Kamil Humański ,&nbsp;Giulio Facchini ,&nbsp;Jenifer Croce ,&nbsp;Dorota Kołbuk ,&nbsp;Philippe Dubois ,&nbsp;Przemysław Gorzelak","doi":"10.1016/j.actbio.2026.01.016","DOIUrl":"10.1016/j.actbio.2026.01.016","url":null,"abstract":"&lt;div&gt;&lt;div&gt;Echinoderm endoskeleton has a unique trabecular microstructure, called stereom, which can exhibit highly ordered geometries. A striking example of these geometries is the recently discovered “diamond-type” stereom, characterized by a diamond triply periodic minimal surface (D-TPMS) and distinguished by exceptional mechanical and structural properties. Despite its promise for engineering applications, the morphogenesis of this microarchitecture remains poorly understood. Here, we applied a multimodal imaging and labeling approach to investigate the developmental processes underlying the formation of the diamond-type stereom in adults of a starfish &lt;em&gt;Protoreaster nodosus&lt;/em&gt;. We showed that this stereom type develops through two principal marginal growth patterns: trabecular trifurcation, which typically occurs horizontally on flat external plate surfaces, oriented approximately along the crystallographic {111} planes of the &lt;span&gt;d&lt;/span&gt;-TPMS; and trabecular bifurcation, which generally occurs along plate edges and between trifurcating zones, aligned with the crystallographic {100} planes of the &lt;span&gt;d&lt;/span&gt;-TPMS. Although these growth patterns may proceed at different rates, they are tightly coordinated, producing the coherent D-TPMS microarchitecture. Furthermore, we demonstrated that F-actin cytoskeletal deposition is consistently associated with active biomineralization fronts in both diamond-type and less ordered, galleried stereom. Notably, the formation of lateral bridges between adjacent stereom trabeculae is often preceded by catenoid-like F-actin structures, suggesting a guiding and templating role for the cytoskeleton in building trabecular connectivity and shaping its curvature. Given the recurrence of saddle-like features across stereom types, we hypothesize that minimal-surface geometries may emerge from tension-driven cytoskeletal dynamics acting as physical templates during biomineralization. Our observations underscore the critical involvement of the cytoskeleton in adult echinoderm biomineralization.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Statement of significance&lt;/h3&gt;&lt;div&gt;Triple periodic minimal surfaces (TPMS) are geometrically regular, three-dimensionally repeating surfaces that minimize area by maintaining zero mean curvature. Among them, the diamond-type (D-TPMS) is notable for exceptional mechanical stability, uniform porosity, and low surface area-to-volume ratio. Although TPMS-like microarchitectures occur in nature, D-TPMS structures, with large lattice parameters (&gt;10 µm) are exceedingly rare; one natural example is the stereom of certain echinoderms. Yet the mechanism governing the formation of such ordered microstructures remains unresolved. We applied a multi-modal approach to investigate principles of diamond-type stereom morphogenesis. Our results provide key insight into the growth dynamics of this microarchitecture and highlight the essential role of the cytoskeleton, particularly F-actin, in guiding trabecular c","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"212 ","pages":"Pages 516-526"},"PeriodicalIF":9.6,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145949451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Biomaterialia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1